Business Context and Reporting Period
This Form 8-K was filed by Wilson Greatbatch Technologies, Inc. on February 22, 2005. The report details a material definitive agreement entered into by its subsidiary, Wilson Greatbatch Ltd. (WGL), with Cardiac Pacemakers, Inc. (d/b/a Guidant Corporation).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a new supply contract.
Material Changes
On February 22, 2005, WGL entered into a Supply Agreement with Guidant Corporation. Key terms include:
- Subject: Purchase of filtered feedthrough materials and components for use in medical devices.
- Duration: Effective February 22, 2005, expiring December 31, 2007.
- Commitments: Guidant Corporation agreed to purchase a minimum quantity of filtered feedthroughs at specified prices.
- Pricing: The agreement specifies prices for both the minimum quantity and any additional purchases during the contract period.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, management commentary on general outlook, or specific risk factors beyond the standard disclosure of the agreement. The company intends to file a copy of the full Agreement with its Quarterly Report on Form 10-Q for the fiscal quarter ended April 1, 2005.
Investor Verification Checklist
- Verify the specific minimum quantity commitments and pricing schedules in the full Supply Agreement.
- Review the upcoming Form 10-Q for the quarter ended April 1, 2005, for the attached copy of the Agreement.
- Assess the impact of this three-year contract on future revenue stability and gross margins.
- Confirm the relationship between Wilson Greatbatch Technologies, Inc. and its subsidiary, Wilson Greatbatch Ltd.